Zoleant Pharmaceuticals International is passionate about the development and global marketing of niche alternative brand pharmaceuticals, unique nutritional supplements, and companion animal products. This dedication ensures access to affordable, high quality animal health products for all.
The commitment and knowledge of our professionals not only allows for Zoleant Pharmaceuticals to create generic pharmaceuticals, but innovative veterinary products. With a true hands-on approach, we focus on the needs of various markets and territories in developing and expanding our product range.
Contribute to the enhancement of the quality of life globally by focusing on the wellbeing of animals and achieving this through our veterinary products.
Building the foundation to becoming the leading provider of alternative brand medicines, while developing and commercializing new animal health products.
Areas of Focus
In order for Zoleant Pharmaceuticals International to fulfill its mission and achieve strategically defined objectives, the Company must methodically concentrate on key focus areas and their developments. These critical focus areas for implementing the Zoleant strategy are:
Quality & Safety: consistently complying with the standards and requirements of those regional authorities in which we have activities while ensuring that the Zoleant understandings of high quality and product safety are met. This is an indispensible aspect of the global pharmaceutical industry.
Efficiency & Flexibility: in order to react to the rapid changes in the global socio and economic conditions, Zoleant seamlessly co-operates with different internal and external divisions to achieve the highest level of customer satisfaction.
Partnerships: Zoleant operations are entirely utilized through our worldwide networks in which the well-managed and transparent partnerships allow for a competitive advantage. It is these partnerships that expedite and push for further global expansion.
Strong Developing Portfolio: product development and their effective launching is a crucial key for the success of the Company and our partners. This requires continuous input from our global partners while our internal teams strive for opportunities in continuous research and development.
Team Culture: Zoleant aspires to provide an attractive and responsible workplace to promote the well-being and continuous development of its personnel through team work, social activities, continued education, and growth.
To ensure continuous growth with maximized efficiency, Zoleant has put into place the following various strategic targets that are monitored with clearly defined indicators:
Innovation: to be able to develop and launch a steady stream of new innovative and cost-effective medicines to our customers.
Communication: being committed to working closely with our global shareholders, partners, and distributors to understand the needs of the customers in those territories to ensure an exceptional level of satisfaction and Zoleant brand awareness.
Sustainability: continuous development to achieve corporate, environmental and operational improvements for ensured sustainability with a focus on occupational safety.
Growth: in order for Zoleant to develop and take manageable risks, the Company must grow faster than our markets of operation. This is an essential business model of the Company as a whole and is not just limited to our geographic strategic partners or the product offerings.